Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 23669227)

1.

Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis.

Collins M, Wilhelm M, Conyers R, Herschtal A, Whelan J, Bielack S, Kager L, Kühne T, Sydes M, Gelderblom H, Ferrari S, Picci P, Smeland S, Eriksson M, Petrilli AS, Bleyer A, Thomas DM.

J Clin Oncol. 2013 Jun 20;31(18):2303-12. doi: 10.1200/JCO.2012.43.8598. Epub 2013 May 13.

2.

Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.

Hong S, Shin SJ, Jung M, Jeong J, Lee YJ, Shin KH, Roh JK, Rha SY.

Oncology. 2011;80(1-2):107-17. doi: 10.1159/000327216. Epub 2011 Jun 14.

PMID:
21677455
3.

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jürgens H, Winkler K.

J Clin Oncol. 2002 Feb 1;20(3):776-90.

PMID:
11821461
4.

Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection.

Berend KR, Pietrobon R, Moore JO, Dibernardo L, Harrelson JM, Scully SP.

J Surg Oncol. 2001 Nov;78(3):162-70.

PMID:
11745799
5.

Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma.

Kim MS, Lee SY, Lee TR, Cho WH, Song WS, Koh JS, Lee JA, Yoo JY, Jeon DG.

Ann Oncol. 2009 May;20(5):955-60. doi: 10.1093/annonc/mdn723. Epub 2009 Jan 19.

6.

Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.

Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jürgens H, Gadner H, Bielack SS; Cooperative German-Austrian-Swiss Osteosarcoma Study Group.

J Clin Oncol. 2003 May 15;21(10):2011-8.

PMID:
12743156
7.

Effect of neoadjuvant treatment in the management of osteosarcomas of the head and neck.

Mücke T, Mitchell DA, Tannapfel A, Wolff KD, Loeffelbein DJ, Kanatas A.

J Cancer Res Clin Oncol. 2014 Jan;140(1):127-31. doi: 10.1007/s00432-013-1550-x. Epub 2013 Nov 26.

PMID:
24276589
8.

Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution.

Cho Y, Jung GH, Chung SH, Kim JY, Choi Y, Kim JD.

Clin Orthop Surg. 2011 Mar;3(1):48-54. doi: 10.4055/cios.2011.3.1.48. Epub 2011 Feb 15.

9.

Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J.

Iwamoto Y, Tanaka K, Isu K, Kawai A, Tatezaki S, Ishii T, Kushida K, Beppu Y, Usui M, Tateishi A, Furuse K, Minamizaki T, Kawaguchi N, Yamawaki S.

J Orthop Sci. 2009 Jul;14(4):397-404. doi: 10.1007/s00776-009-1347-6. Epub 2009 Aug 7.

PMID:
19662473
10.

Treatment of non-metastatic high-grade osteosarcoma (study of 30 cases treated with Scandinavian osteosarcoma protocol XIV and surgery).

Samardziski M, Zafiroski G, Tolevska C, Zafirova-Ivanovska B, Kostadinova-Kunovska S, Kalicanin-Markovska M.

Prilozi. 2008 Dec;29(2):309-23.

PMID:
19259055
11.

Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.

Bernthal NM, Federman N, Eilber FR, Nelson SD, Eckardt JJ, Eilber FC, Tap WD.

Cancer. 2012 Dec 1;118(23):5888-93. doi: 10.1002/cncr.27651. Epub 2012 May 30.

12.

Magnetic resonance imaging is appropriate for determining the osteotomy plane for appendicular osteosarcoma after neoadjuvant chemotherapy.

Han G, Wang Y, Bi WZ, Wang DJ, Lu SB, Zhang L, Zhao B.

Med Oncol. 2012 Jun;29(2):1347-53. doi: 10.1007/s12032-011-9861-8. Epub 2011 Feb 25.

PMID:
21350876
13.

Long-term results after combined modality treatment for non-metastatic osteosarcoma.

Aparicio J, Segura A, Montalar J, Garcerá S, Oltra A, Santaballa A, Yuste A, Pastor M, Munárriz B.

Med Oncol. 1999 Dec;16(4):255-60.

PMID:
10618688
14.

Chemotherapy response analysis for osteosarcom with intra-arterial chemotherapy by subcutaneous implantable delivery system.

Li D, Cui Q, Liu Y, Wang X, Liu C, Liu S, Zeng Y.

Pathol Oncol Res. 2011 Dec;17(4):947-53. doi: 10.1007/s12253-011-9408-5. Epub 2011 Jun 30.

PMID:
21713601
15.

Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: the Rizzoli Institute experience.

Bacci G, Balladelli A, Palmerini E, Alberghini M, Pollastri P, Galletti S, Mercuri M, Picci P.

J Pediatr Hematol Oncol. 2008 Dec;30(12):908-12. doi: 10.1097/MPH.0b013e31817e4aee.

PMID:
19131777
16.
17.

Post operative infection and increased survival in osteosarcoma patients: are they associated?

Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A.

Ann Surg Oncol. 2007 Oct;14(10):2887-95. Epub 2007 Jul 26.

PMID:
17653803
18.

Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.

Rha SY, Chung HC, Gong SJ, Shim KY, Ahn JB, Yang WI, Shin KH, Yoo NC, Kim JH, Roh JK, Lee CI, Kim BS.

Oncol Rep. 1999 May-Jun;6(3):631-7.

PMID:
10203605
19.

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: a report from the European Osteosarcoma Intergroup.

McTiernan A, Jinks RC, Sydes MR, Uscinska B, Hook JM, van Glabbeke M, Bramwell V, Lewis IJ, Taminiau AH, Nooij MA, Hogendoorn PC, Gelderblom H, Whelan JS.

Eur J Cancer. 2012 Mar;48(5):703-12. doi: 10.1016/j.ejca.2011.09.012. Epub 2011 Oct 27.

20.

Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival.

Petrilli AS, de Camargo B, Filho VO, Bruniera P, Brunetto AL, Jesus-Garcia R, Camargo OP, Pena W, Péricles P, Davi A, Prospero JD, Alves MT, Oliveira CR, Macedo CR, Mendes WL, Almeida MT, Borsato ML, dos Santos TM, Ortega J, Consentino E; Brazilian Osteosarcoma Treatment Group Studies III and IV.

J Clin Oncol. 2006 Mar 1;24(7):1161-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk